| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ViewRay, Inc. | Director | Common Stock | 177,315 | $780,186 | $4.40 | 03 Jan 2022 | Direct |
| HUMANIGEN, INC | Director | Stock Option (Right to Buy) | 83,418 | $377,884 | $4.53 | 27 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000121465922009384-xie-yili-kevin-2022-07-27 | HUMANIGEN, INC | 27 Jul 2022 | 1 | $0 | 4 | Director | 29 Jul 2022, 18:30 |
| /report/000162828022000349-xie-yili-kevin-2022-01-03 | ViewRay, Inc. | 03 Jan 2022 | 1 | +$47,998 | 4 | Director | 05 Jan 2022, 16:09 |
| /report/000121465922000272-xie-yili-kevin-2021-12-31 | HUMANIGEN, INC | 31 Dec 2021 | 1 | +$13,274 | 4 | Director | 04 Jan 2022, 17:21 |
| /report/000121465921010654-xie-yili-kevin-2021-10-19 | HUMANIGEN, INC | 19 Oct 2021 | 1 | $0 | 4 | Director | 20 Oct 2021, 17:59 |
| /report/000121465921010652-xie-yili-kevin-2021-10-19 | HUMANIGEN, INC | 19 Oct 2021 | 0 | $0 | 3 | Director | 20 Oct 2021, 17:57 |
| /report/000120919121040907-xie-yili-kevin-2021-06-14 | ViewRay, Inc. | 14 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 16:19 |